Cadence Bank Na Gilead Sciences, Inc. Transaction History

Cadence Bank Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $355,854 - $464,362	-5,878 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$71.28 - $78.92 $88,601 - $98,097	1,243 Added 26.82%	5,878 $454,000
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $40,095 - $46,770	618 Added 15.38%	4,635 $328,000
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $7,211 - $8,791	99 Added 2.53%	4,017 $303,000
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $3,415 - $4,008	48 Added 1.24%	3,918 $281,000
Q3 2017 Oct 27, 2017	BUY	$72.11 - $85.47 $279,065 - $330,768	3,870	3,870 $314,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cadence Bank Na, based on Form 13F filings with the SEC.

Stay updated on Cadence Bank Na with notifications on news.